HAE Stock Price, Chart, Stats & News

Haemonetics Corporation
Save
3.16B
Market cap
33.93x
Current P/E
12.87x
Forward P/E
HAE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 58.49% |
Operating margin | 19.21% |
Pretax margin | 17.23% |
Net margin | 13.31% |
Effective tax rate | 22.77% |
ROA | 7.04% |
ROE | 20.26% |
D/E | 1.34x |
Interest coverage ratio | 12.66x |
HAE valuation
P/E | 33.93x |
P/S | 1.92x |
P/B | 2.77x |
P/CF | 7.46x |
P/FCF | 8.21x |
P/OCF | 7.46x |
PEG | 2.36x |
EV multiple | 4.44x |
About
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system.
Similar securities
Based on sector and market capitalization
Report issue











